AGM Statement and Business Update

AI SummaryClose X

Imaging Biometrics Limited announced the commercial launch of IB Nimble™ 2, an upgraded mobile and web-based platform for clinical collaboration, featuring in-app DICOM viewing and PACS synchronisation to enhance workflow efficiency. The company also highlighted the expanded GE HealthCare distribution agreement for its QSMetric™ product, which aids in monitoring neurological conditions, and reported that its acquired Kirkstall Limited subsidiary, developing organ-on-a-chip technology, achieved year-on-year revenue growth in 2025 with expanding distribution networks. Preparations are underway for journal submission of Phase 1 clinical trial results for oral gallium maltolate, and the company remains confident in accelerating revenue and progressing towards profitability in 2026.

Disclaimer*

UK 100

Latest directors dealings